| Literature DB >> 35911488 |
Shotaro Komeyama1, Takuya Watanabe1, Kenichiro Yamagata2, Norihide Fukushima1.
Abstract
Background: Catheter ablation (CA) has been reported to be an effective therapeutic option for ventricular arrhythmias, even in patients with a left-ventricular assist device (LVAD). However, the issues of right-to-left shunting due to iatrogenic atrial septal defect (iASD) associated with procedures for CA have not been well documented. We describe a rare case of refractory hypoxia associated with right-to-left shunting via iASD after CA through the transseptal approach in an LVAD patient. Case summary: A 52-year-old Asian man with a continuous-flow implantable LVAD and progressive right ventricular (RV) dysfunction was admitted because of refractory ventricular tachycardia (VT) and subsequent right heart failure. Since VT could not be controlled by intravenous administration of multiple antiarrhythmic drugs, VT ablation via the transseptal approach was performed. Ventricular tachycardia was terminated to the sinus rhythm after VT ablation; however, hypoxia associated with significant right-to-left shunting across the iASD was detected. Intensive medical management, such as an adjusted mechanical ventilator to increase pulmonary vascular compliance and adjustment of LVAD pump speed, as well as the use of intravenous inotropes to support impaired RV function successfully stabilized the haemodynamic and improved hypoxia for the disappearance of right-to-left shunting. Echocardiography at 7 months after CA showed that the significant iASD and right-to-left shunting had disappeared. Discussion: The evaluation of RV function prior to VT ablation via the transseptal approach is important in the postoperative management of patients with LVAD, because RV dysfunction may cause refractory hypoxia due to iASD.Entities:
Keywords: Ablation; Case report; Hypoxia; Iatrogenic atrial septal defect; Left-ventricular assist device; Ventricular arrhythmia
Year: 2022 PMID: 35911488 PMCID: PMC9332896 DOI: 10.1093/ehjcr/ytac277
Source DB: PubMed Journal: Eur Heart J Case Rep ISSN: 2514-2119
Right heart catheterization test findings
| Baseline[ | Pre-ablation[ | Post-ablation[ | At discharge[ | |
|---|---|---|---|---|
| Pump speed (r.p.m.) | 5400 | 5400 | 5000 | 5400 |
| PCWP (mmHg) | 12 | 16 | 14 | 3 |
| PAP (mmHg) | 24/16 (20) | 19/14 (16) | 23/18 (20) | 16/6 (10) |
| RVP (mmHg) | 22/∼14 | 21/∼15 | 23/∼20 | 15/∼6 |
| RAP (mmHg) | 13 | 14 | 20 | 6 |
| ABP (mmHg) | 89 | 76 | 73 | 83 |
| CO (L/min) | 5.82 | 6.24 | 3.40 | 4.81 |
| CI (L/min/m2) | 2.85 | 3.00 | 1.66 | 2.53 |
| PVR (Woods) | 1.4 | 0 | 1.8 | 1.5 |
| PAPi | 0.6 | 0.36 | 0.25 | 1.67 |
| PCW/RA | 0.9 | 1.1 | 0.7 | 0.5 |
| RVSWI (g·m/m2) | 250 | 75 | 0 | 126 |
r.p.m., revolutions per min; PCWP, pulmonary capillary wedge pressure; PAP, pulmonary artery pressure; RVP, right ventricular pressure; RAP, right atrium pressure; ABP, arterial blood pressure; CO, cardiac output; CI, cardiac index; PVR, pulmonary vascular resistance; PAPi, pulmonary artery pulsatility index; RVSWI, right ventricular stroke work index.
The baseline RV function deteriorated.
Sustained VT and VT ablation further worsened RV function.
RV function improved 60 days after VT ablation; however, impaired RV function remained.